• Connect
  • Bookmark Us
  • AF Twitter
  • AF YouTube
  • AF LinkedIn
  • Subscribe
  • Subscription Link
Arent Fox
  • Firm

    • History

    • Awards & Recognitions

    • Diversity

      • Overview
      • Diversity Scholarship
      • Employees on Diversity
      • LGBT Initiative
      • Women’s Leadership Development Initiative
    • Alumni

    • Pro Bono

      • Overview
      • Current Pro Bono Work
      • Community Involvement
      • Pro Bono Newsletter
      • Pro Bono Awards & Honors
      • FAQ: Pro Bono & Working at Arent Fox
    • Leadership

      • Firm Management
      • Administrative Leadership
  • Deals & Cases

  • People

  • Practices & Industries

    • Practices

      • Advertising, Promotions & Data Security
      • Government Relations
      • Antitrust & Competition Law
      • Health Care
      • Appellate
      • Insurance & Reinsurance
      • Bankruptcy & Financial Restructuring
      • Intellectual Property
      • Commercial Litigation
      • International Trade
      • Communications, Technology & Mobile
      • Labor & Employment
      • Construction
      • Municipal & Project Finance
      • Consumer Product Safety
      • OSHA
      • Corporate & Securities
      • Political Law
      • ERISA
      • Real Estate
      • Environmental
      • Tax
      • FDA Practice (Food & Drug)
      • Wealth Planning & Management
      • Finance
      • White Collar & Investigations
      • Government Contractor Services
    • Industries

      • Automotive
      • Energy Law & Policy
      • Fashion, Luxury Goods & Retail
      • Government Real Estate & Public Buildings
      • Hospitality
      • Life Sciences
      • Long Term Care & Senior Living
      • Media & Entertainment
      • Medical Devices
      • Nonprofit
      • Sports
  • Newsroom

    • Alerts

    • Events

    • Media Mentions

    • Press Releases

    • Social Media

    • Subscribe

  • Careers

    • Lawyers

    • Law Students

    • Professional Staff

  • Contact

    • Washington, DC

    • New York, NY

    • Los Angeles, CA

    Alerts

    • Newsroom Overview
      • Alerts

        Alerts by Criteria

        E.g., 1 / 22 / 2013
        E.g., 1 / 22 / 2013
      • Events
      • Media Mentions
      • Press Releases
      • Social Media
      • Subscribe

    You are here

    Home » Newsroom » Alerts

    Share

    • Printer-friendly version
    • Send by email
    • A Title
    • A Title
    • A Title
    • A
    • A
    • A

    CARU Finds Sunscreen Advertisement Directed at Children to be Inappropriate

    December 2, 2008

    Last week, the Children's Advertising Review Unit (CARU) of the Council of Better Business Bureaus concluded that Johnson & Johnson’s commercial for its Clean & Clear Moisturizer SPF15 (Clean & Clear) was inappropriately directed at children. The decision was based in part on CARU’s advertising guidelines, which state that products (including drugs) that “pose safety risks” should not be advertised directly to children. As a general matter, cosmetics containing sunscreens are regulated by the US Food and Drug Administration (FDA) as Over-the-Counter (OTC) drugs that are required to be labeled with the warning “Keep out of the reach of children.” Based on the ruling, sunscreens and other OTC drug products, such as lip balms, are examples of products that CARU believes pose safety risks and, as such, should not be advertised to children.  

    Johnson & Johnson argued in its submission to CARU that Clean & Clear was packaged to appeal to a more mature audience and was not intended for use by children. Johnson & Johnson further noted the Clean & Clear commercial had aired during a showing of the television program H2O on Teen Nick (Nickelodeon), a nighttime block of programming aimed at teenagers. Last, Johnson & Johnson stated that Clean & Clear posed no safety risks to children.  The company asked CARU to consider exempting such products from its guidelines as long as they are advertised responsibly. 

    CARU’s decision concerning Clean & Clear is indicative of the increased scrutiny regulators are placing on children’s products, as well as on marketing directed towards children. 

    Please let us know if you have any questions, of if you would like to discuss this matter further. 

    Georgia Ravitz
    ravitz.georgia@arentfox.com
    202.857.8939

    James R. Ravitz
    ravitz.james@arentfox.com
    202.857.8903

    Amy S. Colvin
    colvin.amy@arentfox.com
    202.857.6338

    James H. Hartten
    hartten.james@arentfox.com
    202.857.8983

    Related People

    • James H. Hartten*
    • Georgia Ravitz
    • James R. Ravitz

    Related Practices

    Consumer Product Safety
    FDA Practice (Food & Drug)

    Related Industries

    Life Sciences
    • Firm
    • Deals & Cases
    • People
    • Practices & Industries
    • Newsroom
    • Careers
    • Contact

    Footer Main

    • Firm
    • Deals & Cases
    • People
    • Practices & Industries
    • Newsroom
    • Careers
    • Subscribe
    • Alumni
    • Diversity
    • Legal Notice
    • Privacy Policy
    • Social Media Disclaimer
    • Nondiscrimination
    • Site Map
    • Client/Staff Login

    Offices

    • Washington, DC
      1717 K Street, NW
      Washington, DC 20036
      Tel: 202.857.6000
    • New York, NY
      1675 Broadway
      New York, New York 10019
      Tel: 212.484.3900
    • Los Angeles, CA
      555 West Fifth Street, 48th Floor
      Los Angeles, California 90013
      Tel: 213.629.7400
    • © Copyright 2013 Arent Fox LLP. All Rights Reserved.

      Legal Disclaimer
      Contents may contain attorney advertising under the laws of some states. Prior results do not guarantee a similar outcome.